skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus

Abstract

Ebola viruses and Marburg viruses, members of the filovirus family, are zoonotic pathogens that cause severe disease in people, as highlighted by the latest Ebola virus epidemic in West Africa. Filovirus disease is characterized by uncontrolled virus replication and the activation of host responses that contribute to pathogenesis. Underlying these phenomena is the potent suppression of host innate antiviral responses, particularly the type I interferon response, by viral proteins, which allows high levels of viral replication. Here, in this Review, we describe the mechanisms used by filoviruses to block host innate immunity and discuss the links between immune evasion and filovirus pathogenesis.

Authors:
 [1];  [2];  [3]
  1. Univ. of California, Riverside, CA (United States)
  2. Washington Univ., St. Louis, MO (United States)
  3. Icahn School of Medicine at Mount Sinai, New York, NY (United States)
Publication Date:
Research Org.:
Argonne National Laboratory (ANL), Argonne, IL (United States)
Sponsoring Org.:
U.S. Department of Defense and the Defense Threat Reduction Agency; National Institutes of Health (NIH)
OSTI Identifier:
1351402
Grant/Contract Number:  
U19 AI109945; R01 AI059536; U19 AI109664; U19 AI070489; R01 AI081914; HDTRA1-12-1-0051; HDTRA1-14-1-0013
Resource Type:
Journal Article: Accepted Manuscript
Journal Name:
Nature Reviews Microbiology
Additional Journal Information:
Journal Volume: 13; Journal Issue: 11; Journal ID: ISSN 1740-1526
Publisher:
Springer Nature
Country of Publication:
United States
Language:
ENGLISH
Subject:
60 APPLIED LIFE SCIENCES; Ebola virus; Marburg virus; Viral immune evasion; Viral pathogenesis; Virus-host interactions; Virus structures

Citation Formats

Messaoudi, Ilhem, Amarasinghe, Gaya K., and Basler, Christopher F. Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus. United States: N. p., 2015. Web. doi:10.1038/nrmicro3524.
Messaoudi, Ilhem, Amarasinghe, Gaya K., & Basler, Christopher F. Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus. United States. https://doi.org/10.1038/nrmicro3524
Messaoudi, Ilhem, Amarasinghe, Gaya K., and Basler, Christopher F. 2015. "Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus". United States. https://doi.org/10.1038/nrmicro3524. https://www.osti.gov/servlets/purl/1351402.
@article{osti_1351402,
title = {Filovirus pathogenesis and immune evasion: insights from Ebola virus and Marburg virus},
author = {Messaoudi, Ilhem and Amarasinghe, Gaya K. and Basler, Christopher F.},
abstractNote = {Ebola viruses and Marburg viruses, members of the filovirus family, are zoonotic pathogens that cause severe disease in people, as highlighted by the latest Ebola virus epidemic in West Africa. Filovirus disease is characterized by uncontrolled virus replication and the activation of host responses that contribute to pathogenesis. Underlying these phenomena is the potent suppression of host innate antiviral responses, particularly the type I interferon response, by viral proteins, which allows high levels of viral replication. Here, in this Review, we describe the mechanisms used by filoviruses to block host innate immunity and discuss the links between immune evasion and filovirus pathogenesis.},
doi = {10.1038/nrmicro3524},
url = {https://www.osti.gov/biblio/1351402}, journal = {Nature Reviews Microbiology},
issn = {1740-1526},
number = 11,
volume = 13,
place = {United States},
year = {Tue Oct 06 00:00:00 EDT 2015},
month = {Tue Oct 06 00:00:00 EDT 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record

Citation Metrics:
Cited by: 155 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Mechanisms Underlying Coagulation Abnormalities in Ebola Hemorrhagic Fever: Overexpression of Tissue Factor in Primate Monocytes/Macrophages Is a Key Event
journal, December 2003


Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression
journal, December 2009


Virus Infection Triggers SUMOylation of IRF3 and IRF7, Leading to the Negative Regulation of Type I Interferon Gene Expression
journal, July 2008


DC-SIGN and DC-SIGNR Bind Ebola Glycoproteins and Enhance Infection of Macrophages and Endothelial Cells
journal, January 2003


Marburgvirus Genomics and Association with a Large Hemorrhagic Fever Outbreak in Angola
journal, June 2006


Nitric Oxide Induces Cell Death by Regulating Anti-Apoptotic BCL-2 Family Members
journal, September 2009


Mechanisms of type-I- and type-II-interferon-mediated signalling
journal, May 2005


Evaluation of Immune Globulin and Recombinant Interferon‐α2b for Treatment of Experimental Ebola Virus Infections
journal, February 1999


Response to Imported Case of Marburg Hemorrhagic Fever, the Netherlands
journal, August 2009


Forty Years of Marburg Virus
journal, November 2007


A Novel Immunohistochemical Assay for the Detection of Ebola Virus in Skin: Implications for Diagnosis, Spread, and Surveillance of Ebola Hemorrhagic Fever
journal, February 1999


Marburgvirus Hijacks Nrf2-Dependent Pathway by Targeting Nrf2-Negative Regulator Keap1
journal, March 2014


Effect of Human Recombinant Interleukin-6 and Interleukin-8 on Monocyte Procoagulant Activity
journal, December 1997


Ebola virus glycoprotein-mediated anoikis of primary human cardiac microvascular endothelial cells
journal, April 2004


Infectious Lassa Virus, but Not Filoviruses, Is Restricted by BST-2/Tetherin
journal, August 2010


Isolation of Genetically Diverse Marburg Viruses from Egyptian Fruit Bats
journal, July 2009


The virion glycoproteins of Ebola viruses are encoded in two reading frames and are expressed through transcriptional editing.
journal, April 1996


Anti-Tetherin Activities of HIV-1 Vpu and Ebola Virus Glycoprotein Do Not Involve Removal of Tetherin from Lipid Rafts
journal, March 2012


Pathogenesis of Ebola Hemorrhagic Fever in Cynomolgus Macaques
journal, December 2003


PACT, a protein activator of the interferon-induced protein kinase, PKR
journal, August 1998


Structure of the Ebola VP35 interferon inhibitory domain
journal, January 2009


Crystal Structure of Marburg Virus VP24
journal, February 2014


Molecular Basis for Ebolavirus VP35 Suppression of Human Dendritic Cell Maturation
journal, August 2014


Modular Structure of PACT: Distinct Domains for Binding and Activating PKR
journal, March 2001


Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein
journal, January 2009


The Ebola virus VP35 protein functions as a type I IFN antagonist
journal, October 2000


Depletion of Peripheral Blood T Lymphocytes and NK Cells During the Course of Ebola Hemorrhagic Fever in Cynomolgus Macaques
journal, September 2004


Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment
journal, February 2015


Effects of Ebola Virus Glycoproteins on Endothelial Cell Activation and Barrier Function
journal, July 2005


Cell Adhesion Promotes Ebola Virus Envelope Glycoprotein-Mediated Binding and Infection
journal, April 2008


Human Fatal Zaire Ebola Virus Infection Is Associated with an Aberrant Innate Immunity and with Massive Lymphocyte Apoptosis
journal, October 2010


Molecular Determinants of Ebola Virus Virulence in Mice
journal, January 2006


An Upstream Open Reading Frame Modulates Ebola Virus Polymerase Translation and Virus Replication
journal, January 2013


Amino Acid Residue at Position 79 of Marburg Virus VP40 Confers Interferon Antagonism in Mouse Cells
journal, April 2015


Small molecule inhibitors reveal Niemann–Pick C1 is essential for Ebola virus infection
journal, August 2011


VP24 Is a Molecular Determinant of Ebola Virus Virulence in Guinea Pigs
journal, November 2011


Host Response Dynamics Following Lethal Infection of Rhesus Macaques With Zaire ebolavirus
journal, November 2011


Isolation and Partial Characterisation of a new Virus Causing Acute HÆMorrhagic Fever in Zaire
journal, March 1977


Mutual Antagonism between the Ebola Virus VP35 Protein and the RIG-I Activator PACT Determines Infection Outcome
journal, July 2013


Ebola and Marburg Viruses Replicate in Monocyte‐Derived Dendritic Cells without Inducing the Production of Cytokines and Full Maturation
journal, December 2003


Ebola Virion Attachment and Entry into Human Macrophages Profoundly Effects Early Cellular Gene Expression
journal, October 2011


 5 1-Integrin controls ebolavirus entry by regulating endosomal cathepsins
journal, April 2009


The VP35 protein of Ebola virus impairs dendritic cell maturation induced by virus and lipopolysaccharide
journal, October 2009


Molecular Characterization of Guinea Pig-Adapted Variants of Ebola Virus
journal, November 2000


The Marburg Virus VP24 Protein Interacts with Keap1 to Activate the Cytoprotective Antioxidant Response Pathway
journal, March 2014


Studies of Reservoir Hosts for Marburg Virus
journal, December 2007


Apoptosis Induced In Vitro and In Vivo During Infection by Ebola and Marburg Viruses
journal, February 2000


Structural and Functional Characterization of Reston Ebola Virus VP35 Interferon Inhibitory Domain
journal, June 2010


Preliminary report: isolation of Ebola virus from monkeys imported to USA
journal, March 1990


The Ebola Virus VP24 Protein Prevents hnRNP C1/C2 Binding to Karyopherin α1 and Partially Alters its Nuclear Import
journal, November 2011


Ebola Virus Enters Host Cells by Macropinocytosis and Clathrin-Mediated Endocytosis
journal, November 2011


Filovirus replication and transcription
journal, March 2007


Stimulation of Ebola virus production from persistent infection through activation of the Ras/MAPK pathway
journal, November 2008


Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu
journal, January 2008


RIG-I activation inhibits ebolavirus replication
journal, September 2009


Human Ebola virus infection results in substantial immune activation
journal, March 2015


Ebola virus infection of human PBMCs causes massive death of macrophages, CD4 and CD8 T cell sub-populations in vitro
journal, July 2007


The Ebola Virus Glycoprotein and HIV-1 Vpu Employ Different Strategies to Counteract the Antiviral Factor Tetherin
journal, November 2011


Structural basis for Marburg virus VP35-mediated immune evasion mechanisms
journal, November 2012


Antigenic Subversion: A Novel Mechanism of Host Immune Evasion by Ebola Virus
journal, December 2012


Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak
journal, August 2014


A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: Implications for filovirus budding
journal, November 2000


Ebolavirus VP35 suppresses IFN production from conventional but not plasmacytoid dendritic cells
journal, January 2011


Ebola virus entry requires the cholesterol transporter Niemann–Pick C1
journal, August 2011


Basic Residues within the Ebolavirus VP35 Protein Are Required for Its Viral Polymerase Cofactor Function
journal, August 2010


Filovirus-induced endothelial leakage triggered by infected monocytes/macrophages.
journal, January 1996


Filovirus assembly and budding
journal, January 2006


Phosphatidylserine receptors: Enhancers of enveloped virus entry and infection
journal, November 2014


Lymphocyte Death in a Mouse Model of Ebola Virus Infection
journal, November 2007


Ebola Virus Selectively Inhibits Responses to Interferons, but Not to Interleukin-1β, in Endothelial Cells
journal, April 1999


ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity
journal, February 2008


Emerging and reemerging of filoviruses
book, January 1996


Ebola Zaire Virus Blocks Type I Interferon Production by Exploiting the Host SUMO Modification Machinery
journal, June 2009


The Ebola Virus Interferon Antagonist VP24 Directly Binds STAT1 and Has a Novel, Pyramidal Fold
journal, February 2012


Dendritic Cells
journal, August 2001


Cutting Edge: Impairment of Dendritic Cells and Adaptive Immunity by Ebola and Lassa Viruses
journal, March 2003


Markedly Elevated Levels of Interferon (IFN)‐σ, IFN‐α, Interleukin (IL)‐2, IL‐10, and Tumor Necrosis Factor‐α Associated with Fatal Ebola Virus Infection
journal, February 1999


Transmission of Ebola Hemorrhagic Fever: A Study of Risk Factors in Family Members, Kikwit, Democratic Republic of the Congo, 1995
journal, February 1999


Human Infection Due to Ebola Virus, Subtype Côte d'Ivoire: Clinical and Biologic Presentation
journal, February 1999


Discovery of an Ebolavirus-Like Filovirus in Europe
journal, October 2011


Ebola Virus Inhibits Induction of Genes by Double-Stranded RNA in Endothelial Cells
journal, December 1998


Defective humoral responses and extensive intravascular apoptosis are associated with fatal outcome in Ebola virus-infected patients
journal, April 1999


ORAL SHEDDING OF MARBURG VIRUS IN EXPERIMENTALLY INFECTED EGYPTIAN FRUIT BATS ( ROUSETTUS AEGYPTIACUS )
journal, January 2015


A Mouse Model for Evaluation of Prophylaxis and Therapy of Ebola Hemorrhagic Fever
journal, February 1999


Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury
journal, August 2000


Key Genomic Changes Necessary for an In Vivo Lethal Mouse Marburgvirus Variant Selection Process
journal, February 2011


Genomic Differences between Guinea Pig Lethal and Nonlethal Marburg Virus Variants
journal, November 2007


Reston ebolavirus in Humans and Animals in the Philippines: A Review
journal, November 2011


Pathogenesis of Ebola Hemorrhagic Fever in Primate Models
journal, December 2003


Ebolavirus Is Internalized into Host Cells via Macropinocytosis in a Viral Glycoprotein-Dependent Manner
journal, September 2010


Broad-Spectrum Inhibition of Retroviral and Filoviral Particle Release by Tetherin
journal, November 2008


Ebola Virus VP40-Induced Particle Formation and Association with the Lipid Bilayer
journal, June 2001


Functional CD8 + T Cell Responses in Lethal Ebola Virus Infection
journal, March 2008


An Interferon-α-Induced Tethering Mechanism Inhibits HIV-1 and Ebola Virus Particle Release but Is Counteracted by the HIV-1 Vpu Protein
journal, September 2007


Epidemiologic Investigation of Marburg Virus Disease, Southern Africa, 1975 *
journal, November 1978


Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35
journal, January 2010


Development of a model for marburgvirus based on severe-combined immunodeficiency mice
journal, January 2007


The Ebola Virus VP35 Protein Inhibits Activation of Interferon Regulatory Factor 3
journal, July 2003


Evasion of Interferon Responses by Ebola and Marburg Viruses
journal, September 2009


Emergence of Zaire Ebola Virus Disease in Guinea
journal, October 2014


Interferon-stimulated genes: roles in viral pathogenesis
journal, June 2014


Viral immune modulators perturb the human molecular network by common and unique strategies
journal, July 2012


Marburg Virus Infection Detected in a Common African Bat
journal, August 2007


Marburg Hemorrhagic Fever Associated with Multiple Genetic Lineages of Virus
journal, August 2006


Interferon-Stimulated Genes: A Complex Web of Host Defenses
journal, March 2014


Marburg Virus VP35 Can Both Fully Coat the Backbone and Cap the Ends of dsRNA for Interferon Antagonism
journal, September 2012


Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus
journal, January 2011


Mechanisms and Consequences of Ebolavirus-Induced Lymphocyte Apoptosis
journal, December 2009


Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus
journal, January 2010


The Tyro3 Receptor Kinase Axl Enhances Macropinocytosis of Zaire Ebolavirus
journal, November 2010


Coping with stress: eIF2 kinases and translational control
journal, January 2006


Tyro3 Family-Mediated Cell Entry of Ebola and Marburg Viruses
journal, September 2006


Inflammatory responses in Ebola virus-infected patients
journal, April 2002


The Keap1–Nrf2 Cell Defense Pathway – A Promising Therapeutic Target?
book, January 2012


Homo-oligomerization facilitates the interferon-antagonist activity of the ebolavirus VP35 protein
journal, October 2005


The Ins and Outs of STAT1 Nuclear Transport
journal, August 2003


Works referencing / citing this record:

Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion
journal, May 2019


Therapeutic strategies to target the Ebola virus life cycle
journal, July 2019


Generation and Characterization of Anti-Filovirus Nucleoprotein Monoclonal Antibodies
journal, March 2019


Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
text, January 2016


Immune parameters and outcomes during Ebola virus disease
journal, January 2019


Erratum: Post-exposure treatments for Ebola and Marburg virus infections
journal, May 2018


Retinal Pigment Epithelial Cells are a Potential Reservoir for Ebola Virus in the Human Eye
journal, July 2017


Role of Type I Interferons on Filovirus Pathogenesis
journal, February 2019


A GXXXA Motif in the Transmembrane Domain of the Ebola Virus Glycoprotein Is Required for Tetherin Antagonism
journal, April 2018


Unique human immune signature of Ebola virus disease in Guinea
journal, May 2016


Unique human immune signature of Ebola virus disease in Guinea
journal, May 2016


Ebola Immunity: Gaining a Winning Position in Lightning Chess
journal, July 2018


Post-exposure treatments for Ebola and Marburg virus infections
journal, January 2018


Role of Type I Interferons on Filovirus Pathogenesis
journal, February 2019


When Dendritic Cells Go Viral: The Role of Siglec-1 in Host Defense and Dissemination of Enveloped Viruses
journal, December 2019


Receptor-Mediated Host Cell Preference of a Bat-Derived Filovirus, Lloviu Virus
journal, October 2020


In vivo Ebola virus infection leads to a strong innate response in circulating immune cells
journal, September 2016


Global research trends of World Health Organization’s top eight emerging pathogens
journal, February 2017


Extracellular Vesicles and Ebola Virus: A New Mechanism of Immune Evasion
journal, May 2019


Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction
journal, November 2016


Aerosol Transmission of Filoviruses
journal, May 2016


Inhibition of Innate Immune Responses Is Key to Pathogenesis by Arenaviruses
journal, February 2016


The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses
journal, December 2016


Monoclonal antibodies for the treatment of Ebola virus disease
journal, October 2016


Disabling of lymphocyte immune response by Ebola virus
journal, April 2018


Mécanismes d’échappement des filovirus à l’immunité innée
journal, August 2018


Ebola virus VP30 and nucleoprotein interactions modulate viral RNA synthesis
journal, June 2017


Ebola Virus VP40 Modulates Cell Cycle and Biogenesis of Extracellular Vesicles
journal, August 2018


Global research trends of World Health Organization’s top eight emerging pathogens
journal, February 2017


Bats and Viruses: Emergence of Novel Lyssaviruses and Association of Bats with Viral Zoonoses in the EU
journal, February 2019


Ebola virus VP30 and nucleoprotein interactions modulate viral RNA synthesis
journal, June 2017


The roles of ebolavirus glycoproteins in viral pathogenesis
journal, November 2016


In vivo Ebola virus infection leads to a strong innate response in circulating immune cells
journal, September 2016


Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions
journal, January 2017


Melatonin as an antioxidant: under promises but over delivers
journal, September 2016


Persistence and Sexual Transmission of Filoviruses
journal, December 2018


The Ebola virus VP35 protein binds viral immunostimulatory and host RNAs identified through deep sequencing
journal, June 2017


When Dendritic Cells Go Viral: The Role of Siglec-1 in Host Defense and Dissemination of Enveloped Viruses
journal, December 2019


The ongoing evolution of antibody-based treatments for Ebola virus infection
journal, March 2017


Immune parameters and outcomes during Ebola virus disease
journal, January 2019


Phenotypic Prioritization of Diphyllin Derivatives That Block Filoviral Cell Entry by Vacuolar (H + )-ATPase Inhibition
journal, November 2018